News
Mustang Bio
MBIO · NASDAQ
$0.3795+$0.0065 (+1.74%)TodayMarket closed ·
Prev close $0.373
Latest news
- NewsMohd Haider
Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On
- Press releaseGlobe Newswire
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
- NewsHenry Khederian
Mustang Bio (MBIO) Stock Explodes 260% After FDA Grants Key Cancer Drug Designation
- NewsAvi Kapoor
Dow Dips 1%; Mustang Bio Shares Spike Higher
- NewsAvi Kapoor
Nasdaq Falls Over 100 Points; Capgemini To Acquire WNS
- Press releaseGlobe Newswire
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
US Stocks Mixed; UniFirst Shares Fall After Q3 Results
- NewsAvi Kapoor
Why Greenbrier Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
- Press releaseGlobe Newswire
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
- Press releaseGlobe Newswire
Mustang Bio Announces Closing of $8 Million Public Offering
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
Mustang Bio Announces Pricing of $8 Million Public Offering
- NewsAvi Kapoor
Dow Gains Over 200 Points; Signet Jewelers Shares Plunge
- NewsAvi Kapoor
Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher
- NewsAvi Kapoor
Nasdaq Jumps 150 Points; US Producer Prices Increase 0.2% In December
- Press releaseGlobe Newswire
Mustang Bio Announces Reverse Stock Split
- Press releaseGlobe Newswire
Mustang Bio Receives Positive Listing Determination from Nasdaq
- Press releaseGlobe Newswire
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
- Press releaseGlobe Newswire
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- NewsAvi Kapoor
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
- NewsJuan Spínelli
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.